![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 17625 |
FusionGeneSummary for IPMK_CXCL12 |
![]() |
Fusion gene information | Fusion gene name: IPMK_CXCL12 | Fusion gene ID: 17625 | Hgene | Tgene | Gene symbol | IPMK | CXCL12 | Gene ID | 253430 | 6387 |
Gene name | inositol polyphosphate multikinase | C-X-C motif chemokine ligand 12 | |
Synonyms | - | IRH|PBSF|SCYB12|SDF1|TLSF|TPAR1 | |
Cytomap | 10q21.1 | 10q11.21 | |
Type of gene | protein-coding | protein-coding | |
Description | inositol polyphosphate multikinaseinositol 1,3,4,6-tetrakisphosphate 5-kinase | stromal cell-derived factor 1chemokine (C-X-C motif) ligand 12intercrine reduced in hepatomaspre-B cell growth-stimulating factor | |
Modification date | 20180519 | 20180527 | |
UniProtAcc | Q8NFU5 | P48061 | |
Ensembl transtripts involved in fusion gene | ENST00000373935, | ENST00000395795, ENST00000374429, ENST00000395793, ENST00000374426, ENST00000343575, ENST00000395794, ENST00000496375, | |
Fusion gene scores | * DoF score | 1 X 1 X 1=1 | 4 X 2 X 4=32 |
# samples | 1 | 4 | |
** MAII score | log2(1/1*10)=3.32192809488736 | log2(4/32*10)=0.321928094887362 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: IPMK [Title/Abstract] AND CXCL12 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | CXCL12 | GO:0033622 | integrin activation | 29301984 |
Tgene | CXCL12 | GO:0045785 | positive regulation of cell adhesion | 23620790 |
Tgene | CXCL12 | GO:0060326 | cell chemotaxis | 18308860 |
Tgene | CXCL12 | GO:0070098 | chemokine-mediated signaling pathway | 20388803 |
Tgene | CXCL12 | GO:0090026 | positive regulation of monocyte chemotaxis | 18802065 |
Tgene | CXCL12 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage | 20388803 |
Tgene | CXCL12 | GO:1903237 | negative regulation of leukocyte tethering or rolling | 18308860 |
Tgene | CXCL12 | GO:2000406 | positive regulation of T cell migration | 23620790 |
Tgene | CXCL12 | GO:2000669 | negative regulation of dendritic cell apoptotic process | 15059845 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | LUAD | TCGA-38-4632-01A | IPMK | chr10 | 59986804 | - | CXCL12 | chr10 | 44793345 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000373935 | ENST00000395795 | IPMK | chr10 | 59986804 | - | CXCL12 | chr10 | 44793345 | - |
5CDS-intron | ENST00000373935 | ENST00000374429 | IPMK | chr10 | 59986804 | - | CXCL12 | chr10 | 44793345 | - |
5CDS-intron | ENST00000373935 | ENST00000395793 | IPMK | chr10 | 59986804 | - | CXCL12 | chr10 | 44793345 | - |
5CDS-intron | ENST00000373935 | ENST00000374426 | IPMK | chr10 | 59986804 | - | CXCL12 | chr10 | 44793345 | - |
5CDS-intron | ENST00000373935 | ENST00000343575 | IPMK | chr10 | 59986804 | - | CXCL12 | chr10 | 44793345 | - |
5CDS-intron | ENST00000373935 | ENST00000395794 | IPMK | chr10 | 59986804 | - | CXCL12 | chr10 | 44793345 | - |
5CDS-intron | ENST00000373935 | ENST00000496375 | IPMK | chr10 | 59986804 | - | CXCL12 | chr10 | 44793345 | - |
Top |
FusionProtFeatures for IPMK_CXCL12 |
![]() |
Hgene | Tgene |
IPMK | CXCL12 |
Inositol phosphate kinase with a broad substratespecificity. Has a preference for inositol 1,4,5-trisphosphate(Ins(1,4,5)P3) and inositol 1,3,4,6-tetrakisphosphate(Ins(1,3,4,6)P4). {ECO:0000269|PubMed:12027805,ECO:0000269|PubMed:12223481}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for IPMK_CXCL12 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for IPMK_CXCL12 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
IPMK | CEP120, TRAF6 | CXCL12 | FN1, CXCL12, PF4, VCAN, CXCR4, DAZAP2 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for IPMK_CXCL12 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Tgene | CXCL12 | P48061 | DB06822 | Tinzaparin | Stromal cell-derived factor 1 | small molecule | approved |
Top |
RelatedDiseases for IPMK_CXCL12 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | CXCL12 | C0027626 | Neoplasm Invasiveness | 3 | CTD_human |
Tgene | CXCL12 | C0027627 | Neoplasm Metastasis | 2 | CTD_human |
Tgene | CXCL12 | C0022116 | Ischemia | 1 | CTD_human |
Tgene | CXCL12 | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
Tgene | CXCL12 | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
Tgene | CXCL12 | C0266929 | Chronic Periodontitis | 1 | CTD_human |
Tgene | CXCL12 | C0345967 | Malignant mesothelioma | 1 | CTD_human |
Tgene | CXCL12 | C1458155 | Mammary Neoplasms | 1 | CTD_human |
Tgene | CXCL12 | C1956346 | Coronary Artery Disease | 1 | CTD_human |
Tgene | CXCL12 | C2239176 | Liver carcinoma | 1 | CTD_human |